Publications - Yogish C. Kudva, MBBS

Back to research profile

  1. Kudva YC, Erickson JR, Parsaik A, Rostambeigi N, Thapa P, Abraham RS. Comprehensive immune monitoring reveals profound immunological changes in pancreas after kidney (PAK) transplant recipients. Hum Immunol. 2013 Jun; 74(6):738-45. Epub 2013 Mar 07.
    View PubMed
  2. Bower RS, Mallory GW, Nwojo M, Kudva YC, Flemming KD, Meyer FB. Moyamoya Disease in a Primarily White, Midwestern US Population: Increased Prevalence of Autoimmune Disease. Stroke. 2013 May 07. [Epub ahead of print]
    View PubMed
  3. Bharucha AE, Low P, Camilleri M, Veil E, Burton D, Kudva Y, Shah P, Gehrking T, Zinsmeister AR. A randomised controlled study of the effect of cholinesterase inhibition on colon function in patients with diabetes mellitus and constipation. Gut. 2013 May; 62(5):708-15. Epub 2012 Jun 07.
    View PubMed
  4. Dong M, Parsaik AK, Kremers W, Sun A, Dean P, Prieto M, Cosio FG, Gandhi MJ, Zhang L, Smyrk TC, Stegall MD, Kudva YC. Acute pancreas allograft rejection is associated with increased risk of graft failure in pancreas transplantation. Am J Transplant. 2013 Apr; 13(4):1019-25. Epub 2013 Feb 22.
    View PubMed
  5. Ferrara MJ, Lohse C, Kudva YC, Farnell MB, Que FG, Reid-Lombardo KM, Donohue JH, Nagorney DM, Chari ST, Vege SS, Kendrick ML. Immediate post-resection diabetes mellitus after pancreaticoduodenectomy: incidence and risk factors. HPB (Oxford). 2013 Mar; 15(3):170-4. Epub 2012 Sep 10.
    View PubMed
  6. Basu A, Kudva YC, Basu R. GPR40 modulators: new kid on the block. Diabetes Care. 2013 Feb; 36(2):185-7.
    View PubMed
  7. Thatava T, Kudva YC, Edukulla R, Squillace K, De Lamo JG, Khan YK, Sakuma T, Ohmine S, Terzic A, Ikeda Y. Intrapatient variations in type 1 diabetes-specific iPS cell differentiation into insulin-producing cells. Mol Ther. 2013 Jan; 21(1):228-39. Epub 2012 Nov 27.
    View PubMed
  8. Parsaik AK, Carter RE, Myers LA, Basu A, Kudva YC. Hypoglycemia requiring ambulance services in patients with type 2 diabetes is associated with increased long-term mortality. Endocr Pract. 2013 Jan-Feb; 19(1):29-35.
    View PubMed
  9. Manohar C, Levine JA, Nandy DK, Saad A, Dalla Man C, McCrady-Spitzer SK, Basu R, Cobelli C, Carter RE, Basu A, Kudva YC. The effect of walking on postprandial glycemic excursion in patients with type 1 diabetes and healthy people. Diabetes Care. 2012 Dec; 35(12):2493-9. Epub 2012 Aug 08.
    View PubMed
  10. Saad A, Dalla Man C, Nandy DK, Levine JA, Bharucha AE, Rizza RA, Basu R, Carter RE, Cobelli C, Kudva YC, Basu A. Diurnal pattern to insulin secretion and insulin action in healthy individuals. Diabetes. 2012 Nov; 61(11):2691-700. Epub 2012 Jun 29.
    View PubMed
  11. Parsaik AK, Carter RE, Myers LA, Geske JR, Smith SA, Levine JA, Basu A, Kudva YC. Population-based study of hypoglycemia in patients with type 1 diabetes mellitus requiring emergency medical services. Endocr Pract. 2012 Nov-Dec; 18(6):834-41.
    View PubMed
  12. Spanogle JP, Kudva YC, Dierkhising RA, Kremers WK, Roenigk RK, Brewer JD, Prieto M, Otley CC. Skin cancer after pancreas transplantation. J Am Acad Dermatol. 2012 Oct; 67(4):563-9. Epub 2012 Feb 15.
    View PubMed
  13. Parsaik AK, Carter RE, Myers LA, Dong M, Basu A, Kudva YC. Outcomes of community-dwelling adults without diabetes mellitus who require ambulance services for hypoglycemia. J Diabetes Sci Technol. 2012 Sep; 6(5):1107-13. Epub 2012 Sep 01.
    View PubMed
  14. Wauters RP, Cosio FG, Suarez Fernandez ML, Kudva Y, Shah P, Torres VE. Cardiovascular consequences of new-onset hyperglycemia after kidney transplantation. Transplantation. 2012 Aug 27; 94(4):377-82.
    View PubMed
  15. Buse JB, Kudva YC, Battelino T, Davis SN, Shin J, Welsh JB. Effects of sensor-augmented pump therapy on glycemic variability in well-controlled type 1 diabetes in the STAR 3 study. Diabetes Technol Ther. 2012 Jul; 14(7):644-7. Epub 2012 Apr 23.
    View PubMed
  16. Barton FB, Rickels MR, Alejandro R, Hering BJ, Wease S, Naziruddin B, Oberholzer J, Odorico JS, Garfinkel MR, Levy M, Pattou F, Berney T, Secchi A, Messinger S, Senior PA, Maffi P, Posselt A, Stock PG, Kaufman DB, Luo X, Kandeel F, Cagliero E, Turgeon Improvement in outcomes of clinical islet transplantation: 1999-2010. Diabetes Care. 2012 Jul; 35(7):1436-45.
    View PubMed
  17. Rajagopalan G, Kudva YC, David CS. Is HOT a cool treatment for type 1 diabetes? Diabetes. 2012 Jul; 61(7):1664-6.
    View PubMed
  18. Dong M, Parsaik AK, Eberhardt NL, Basu A, Cosio FG, Kudva YC. Cellular and physiological mechanisms of new-onset diabetes mellitus after solid organ transplantation. Diabet Med. 2012 Jul; 29(7):e1-12.
    View PubMed
  19. Kudva YC, Ohmine S, Greder LV, Dutton JR, Armstrong A, De Lamo JG, Khan YK, Thatava T, Hasegawa M, Fusaki N, Slack JM, Ikeda Y. Transgene-free disease-specific induced pluripotent stem cells from patients with type 1 and type 2 diabetes. Stem Cells Transl Med. 2012 Jun; 1(6):451-61. Epub 2012 May 30.
    View PubMed
  20. Dutta T, Chai HS, Ward LE, Ghosh A, Persson XM, Ford GC, Kudva YC, Sun Z, Asmann YW, Kocher JP, Nair KS. Concordance of changes in metabolic pathways based on plasma metabolomics and skeletal muscle transcriptomics in type 1 diabetes. Diabetes. 2012 May; 61(5):1004-16. Epub 2012 Mar 13.
    View PubMed
  21. Ohmine S, Squillace KA, Hartjes KA, Deeds MC, Armstrong AS, Thatava T, Sakuma T, Terzic A, Kudva Y, Ikeda Y. Reprogrammed keratinocytes from elderly type 2 diabetes patients suppress senescence genes to acquire induced pluripotency. Aging (Albany NY). 2012 Jan; 4(1):60-73.
    View PubMed
  22. Parsaik AK, Carter RE, Pattan V, Myers LA, Kumar H, Smith SA, Russi CS, Levine JA, Basu A, Kudva YC. Population-based study of severe hypoglycemia requiring emergency medical service assistance reveals unique findings. J Diabetes Sci Technol. 2012 Jan; 6(1):65-73. Epub 2012 Jan 1.
    View PubMed
  23. Hiddinga HJ, Sakagashira S, Ishigame M, Madde P, Sanke T, Nanjo K, Kudva YC, Lee JJ, van Deursen J, Eberhardt NL. Expression of wild-type and mutant S20G hIAPP in physiologic knock-in mouse models fails to induce islet amyloid formation, but induces mild glucose intolerance. Journal of Diabetes Investigation. 2012; 3(2):138-47.
  24. Parsaik AK, Carter RE, Myers LA, Geske JR, Smith SA, Levine J, Basu A, Kudva YC. Population-based study of hypoglycemia in patients with type 1 diabetes mellitus requiring emergency medical services. Endocr Pract. 2012; 18(6):834-41.
  25. Dong M, Parsaik AK, Erwin PJ, Farnell MB, Murad MH, Kudva YC. Systematic review and meta-analysis: islet autotransplantation after pancreatectomy for minimizing diabetes. Clin Endocrinol (Oxf). 2011 Dec; 75(6):771-9.
    View PubMed
  26. Parsaik AK, Bhalla T, Dong M, Rostambeigi N, Dierkhising RA, Dean P, Abraham R, Prieto M, Kremers WK, Razonable RR, Kudva YC. Epidemiology of cytomegalovirus infection after pancreas transplantation. Transplantation. 2011 Nov 15; 92(9):1044-50.
    View PubMed
  27. Pattan V, Parsaik A, Brown JK, Kudva YC, Vlahakis N, Basu A. Glucose control in Mayo Clinic intensive care units. J Diabetes Sci Technol. 2011 Nov; 5(6):1420-6. Epub 2011 Nov 01.
    View PubMed
  28. Gandhi GY, Kovalaske M, Kudva Y, Walsh K, Elamin MB, Beers M, Coyle C, Goalen M, Murad MS, Erwin PJ, Corpus J, Montori VM, Murad MH. Efficacy of continuous glucose monitoring in improving glycemic control and reducing hypoglycemia: a systematic review and meta-analysis of randomized trials. J Diabetes Sci Technol. 2011 Jul; 5(4):952-65. Epub 2011 Jul 01.
    View PubMed
  29. Deeds MC, Anderson JM, Armstrong AS, Gastineau DA, Hiddinga HJ, Jahangir A, Eberhardt NL, Kudva YC. Single dose streptozotocin-induced diabetes: considerations for study design in islet transplantation models. Lab Anim. 2011 Jul; 45(3):131-40. Epub 2011 Apr 08.
    View PubMed
  30. Rostambeigi N, Lanza IR, Dzeja PP, Deeds MC, Irving BA, Reddi HV, Madde P, Zhang S, Asmann YW, Anderson JM, Schimke JM, Nair KS, Eberhardt NL, Kudva YC. Unique cellular and mitochondrial defects mediate FK506-induced islet beta-cell dysfunction. Transplantation. 2011 Mar 27; 91(6):615-23.
    View PubMed
  31. Kudva YC, Basu A. Elevated HbA1c levels (5.7% to 6.4%) had low accuracy for diagnosing prediabetes. ACP J Club. 2011 Mar 20; 154(3):10.
  32. Kudva YC, Basu A. ACP Journal Club. Elevated HbA1c levels (5.7% to 6.4%) had low accuracy for diagnosing prediabetes. Ann Intern Med. 2011 Mar 15; 154(6):JC3-11.
    View PubMed
  33. Kudva YC, Basu A. Ultra-long-acting insulins for a lifestyle-related pandemic. Lancet. 2011 Mar 12; 377(9769):880-1.
    View PubMed
  34. Thatava T, Nelson TJ, Edukulla R, Sakuma T, Ohmine S, Tonne JM, Yamada S, Kudva Y, Terzic A, Ikeda Y. Indolactam V/GLP-1-mediated differentiation of human iPS cells into glucose-responsive insulin-secreting progeny. Gene Ther. 2011 Mar; 18(3):283-93. Epub 2010 Nov 04.
    View PubMed
  35. Ohmine S, Dietz AB, Deeds MC, Hartjes KA, Miller DR, Thatava T, Sakuma T, Kudva YC, Ikeda Y. Induced pluripotent stem cells from GMP-grade hematopoietic progenitor cells and mononuclear myeloid cells. Stem Cell Res Ther. 2011; 2(6):46. Epub 2011 Nov 16.
    View PubMed
  36. Pattan V, Parsaik AK, Brown JK, Kudva YC, Vlahakis N, Basu A. Mayo Clinic Experience: Insulin Infusion Protocol with significantly reduced Hypoglycemia in the Intensive Care Unit. Journal of Diabetes Science and Technology (. 2011; In Press).
  37. Hiddinga HJ, Sakagashira S, Ishigame M, Madde P, Sanke T, Nanjo K, Kudva YC, Lee JL, van Deursen J, Eberhardt NL. Expression of wild-type and mutant S20G hIAPP in physiologic knock-in mouse models fails to induce islet amyloid formation, but induces mild glucose intolerance. Journal of Diabetes Investigation J Diab Invest (. 2011; In Press).
  38. Spanogle JP, Kudva YC, Dierkhising RA, Kremers WK, Roenigk RK, Brewer JD, Prieto M, Otley CC. Skin Cancer Following Pancreas Transplant. Journal of the American Academy of Dermatology (. 2011; In Press).
  39. Parsaik AK, Carter RE, Pattan V, Myers LA, Kumar H, Smith SA, Russi CS, Levine JA, Basu A, Kudva YC. Population Based Study of Severe Hypoglycemia requiring Emergency Medical Service Assistance reveals Unique Findings. J Diab Sci Tech (. 2011; In Press).
  40. Thatava T, Armstrong A, De Lamo JG, Edukulla R, Sakuma T, Ohmine S, Sundsbak J, Harris PC, Kudva YC, Ikeda Y. Successful disease-specific iPS cell generation from patients with kidney transplantation. Stem Cell Research and Therapy (. 2011; In Press).
  41. Saad A, Dalla Man C, Nandy DK, Levine JA, Bharucha AE, Rizza RA, Basu R, Cobelli C, Kudva YC, Basu A. Circadian Pattern to Insulin Secretion and Insulin Action in healthy individuals. Diabetes (. 2011; revision submitted).
  42. Thatava T, Armstrong AS, De Lamo JG, Edukulla R, Khan YK, Sakuma T, Ohmine S, Sundsbak JL, Harris PC, Kudva YC, Ikeda Y. Successful disease-specific induced pluripotent stem cell generation from patients with kidney transplantation. Stem Cell Res Ther. 2011; 2(6):48. Epub 2011 Dec 06.
    View PubMed
  43. Dong M, Parsaik AK, Eberhardt NL, Basu A, Cosio FG, Kudva YC. Cellular and Physiologic Mechanisms of New Onset Diabetes Mellitus after Solid Organ Transplantation. Diab Med (. 2011; In Press).
  44. Parsaik AK, Murad MH, Sathananthan A, Moorthy V, Erwin PJ, Chari S, Carter RE, Farnell MB, Vege SS, Sarr MG, Kudva YC. Metabolic and target organ outcomes after total pancreatectomy: Mayo Clinic experience and meta-analysis of the literature. Clin Endocrinol (Oxf). 2010 Dec; 73(6):723-31.
    View PubMed
  45. Rostambeigi N, Kudva YC, John S, Mailankody S, Pedersen RA, Dean PG, Prieto M, Cosio FG, Kremers WK, Walker RC, Abraham RS, Stegall MD. Epidemiology of infections requiring hospitalization during long-term follow-up of pancreas transplantation. Transplantation. 2010 May 15; 89(9):1126-33.
    View PubMed
  46. Eckel-Passow JE, Mahoney DW, Oberg AL, Zenka RM, Johnson KL, Nair KS, Kudva YC, Bergen HR III, Therneau TM. Bi-linear regression for 18O quantification: Modeling across the elution profile. Journal of Proteomics and Bioinformatics. 2010; 3(12):323-9.
  47. Issa N, Amer H, Dean PG, Kremers WK, Kudva YC, Rostambeigi N, Cosio FG, Larson TS, Habermann TM, Stegall MD, Griffin MD. Posttransplant lymphoproliferative disorder following pancreas transplantation. Am J Transplant. 2009 Aug; 9(8):1894-902. Epub 2009 Jun 10.
    View PubMed
  48. Winters JL, Tran SA, Gastineau DA, Padley DJ, Dean PG, Kudva YC. Organ procurement organization compliance with 21 CFR 1271: a challenge for allogeneic pancreatic islet cell transplantation programs. Am J Transplant. 2009 Jun; 9(6):1472-6. Epub 2009 May 13.
    View PubMed
  49. Fatourechi MM, Kudva YC, Murad MH, Elamin MB, Tabini CC, Montori VM. Clinical review: Hypoglycemia with intensive insulin therapy: a systematic review and meta-analyses of randomized trials of continuous subcutaneous insulin infusion versus multiple daily injections. J Clin Endocrinol Metab. 2009 Mar; 94(3):729-40. Epub 2008 Dec 16.
    View PubMed
  50. Fatourechi M, Kudva YC, Hassan Murad M, Tabini C, Montori VM. Intensive insulin therapy with continuous subcutaneous insulin infusion versus multiple daily injections: systematic review and meta-analysis of randomized controlled trials. J Clin Endo Metab ePub. Dec. 2008.
  51. Gandhi GY, Murad MH, Flynn DN, Elamin MB, Erwin PJ, Montori VM, Kudva YC. Immunotherapeutic agents in type 1 diabetes: a systematic review and meta-analysis of randomized trials. Clin Endocrinol (Oxf) 2008 Aug; 69(2):244-52. Epub 2008 Jan 10.
    View PubMed
  52. Sheikh-Ali M, Karon BS, Basu A, Kudva YC, Muller LA, Xu J, Schwenk WF, Miles JM. Can serum beta-hydroxybutyrate be used to diagnose diabetic ketoacidosis? Diabetes Care. 2008 Apr; 31(4):643-7. Epub 2008 Jan 09.
    View PubMed
  53. Cosio FG, Hickson LJ, Griffin MD, Stegall MD, Kudva Y. Patient survival and cardiovascular risk after kidney transplantation: the challenge of diabetes. Am J Transplant. 2008 Mar; 8(3):593-9.
    View PubMed
  54. Dean PG, Kudva YC, Stegall MD. Long-term benefits of pancreas transplantation. Curr Opin Organ Transplant. 2008 Feb; 13(1):85-90.
    View PubMed
  55. Dean PG, Kudva YC, Larson TS, Kremers WK, Stegall MD. Posttransplant diabetes mellitus after pancreas transplantation. Am J Transplant. 2008 Jan; 8(1):175-82. Epub 2007 Oct 31.
    View PubMed
  56. Rajagopalan G, Mangalam AK, Sen MM, Kudva YC, David CS. Distinct local immunogenic stimuli dictate differential requirements for CD4+ and CD8+ T cell subsets in the pathogenesis of spontaneous autoimmune diabetes. Autoimmunity. 2007 Nov; 40(7):489-96.
    View PubMed
  57. Ajaz F, Kudva YC, Erwin PJ. Residual dysphasia after severe hypoglycemia in a patient with immune-mediated primary adrenal insufficiency and type 1 diabetes mellitus: case report and systematic review of the literature. Endocr Pract. 2007 Jul-Aug; 13(4):384-8.
    View PubMed
  58. Kudva YC, Basu A, Jenkins GD, Pons GM, Vogelsang DA, Rizza RA, Smith SA, Isley WL. Glycemic variation and hypoglycemia in patients with well-controlled type 1 diabetes on a multiple daily insulin injection program with use of glargine and ultralente as basal insulin. Endocr Pract. 2007 May-Jun; 13(3):244-50.
    View PubMed
  59. Rajagopalan G, Mangalam AK, Sen MM, Cheng S, Kudva YC, David CS. Autoimmunity in HLA-DQ8 transgenic mice expressing granulocyte/macrophage-colony stimulating factor in the beta cells of islets of Langerhans. Autoimmunity. 2007 May; 40(3):169-79.
    View PubMed
  60. Pissios P, Ozcan U, Kokkotou E, Okada T, Liew CW, Liu S, Peters JN, Dahlgren G, Karamchandani J, Kudva YC, Kurpad AJ, Kennedy RT, Maratos-Flier E, Kulkarni RN. Melanin concentrating hormone is a novel regulator of islet function and growth. Diabetes. 2007 Feb; 56(2):311-9.
    View PubMed
  61. Anderson JM, Deeds MC, Armstrong AS, Gastineau DA, Kudva YC. Utilization of a test gradient enhances islet recovery from deceased donor pancreases. Cytotherapy. 2007; 9(7):630-6.
    View PubMed
  62. Kudva YC, Basu A, Jenkins GD, Pons GM, Quandt LL, Gebel JA, Vogelsang DA, Smith SA, Rizza RA, Isley WL. Glycemic Variation and Hypoglycemia in well controlled patients with type 1 diabetes on Multiple Daily Insulin Injection Program using Glargine and Ultralente as basal insulin. Diabetes Research and Clin Practice. 2007.
  63. Kudva YC, Basu A. Adjunctive inhaled insulin before meals improved glycaemic control more than adjunctive metformin in type 2 diabetes mellitus. Evid Based Med. 2006 Dec; 11(6):176.
    View PubMed
  64. Rajagopalan G, Kudva YC, Sen MM, Marietta EV, Murali N, Nath K, Moore J, David CS. IL-10-deficiency unmasks unique immune system defects and reveals differential regulation of organ-specific autoimmunity in non-obese diabetic mice. Cytokine. 2006 Apr; 34(1-2):85-95.
    View PubMed
  65. Mahmud FH, Murray JA, Kudva YC, Zinsmeister AR, Dierkhising RA, Lahr BD, Dyck PJ, Kyle RA, El-Youssef M, Burgart LJ, Van Dyke CT, Brogan DL, Melton LJ 3rd. Celiac disease in type 1 diabetes mellitus in a North American community: prevalence, serologic screening, and clinical features. Mayo Clin Proc. 2005 Nov; 80(11):1429-34.
    View PubMed
  66. Cosio FG, Kudva Y, van der Velde M, Larson TS, Textor SC, Griffin MD, Stegall MD. New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation. Kidney Int. 2005 Jun; 67(6):2415-21.
    View PubMed
  67. Kudva Y, Hunt D. Trandolapril delayed persistent microalbuminuria in hypertension, type 2 diabetes, and normoalbuminuria. ACP J Club. 2005 May-Jun; 142(3):65.
    View PubMed
  68. Heimbach JK, Taler SJ, Prieto M, Cosio FG, Textor SC, Kudva YC, Chow GK, Ishitani MB, Larson TS, Stegall MD. Obesity in living kidney donors: Clinical characteristics and outcomes in the era of laparoscopic donor nephrectomy. Am J Transplant. 2005 May; 5(5):1057-64.
    View PubMed
  69. Kudva YC, Basu A, Jenkins GD, Pons GM, Quandt LL, Gebel JA, Vogelsang DA, Smith SA, Rizza RA, Isley WL. Randomized controlled clinical trial of glargine versus ultralente insulin in the treatment of type 1 diabetes. Diabetes Care. 2005 Jan; 28(1):10-4.
    View PubMed
  70. Krajicek BJ, Kudva YC. Hurley HA. Potentially important contribution of dextrose used as diluent to hyperglycemia in hospitalized patients Diabetes Care. 2005; 28(4):981-2.
  71. Montori VM, Helgemoe PK, Guyatt GH, Dean DS, Leung TW, Smith SA, Kudva YC. Telecare for patients with type 1 diabetes and inadequate glycemic control: a randomized controlled trial and meta-analysis. Diabetes Care. 2004 May; 27(5):1088-94.
    View PubMed
  72. Larson TS, Bohorquez H, Rea DJ, Nyberg SL, Prieto M, Sterioff S, Textor SC, Schwab TR, Griffin MD, Gloor JM, Kudva YC, Kremers WK, Stegall MD. Pancreas-after-kidney transplantation: An increasingly attractive alternative to simultaneous pancreas-kidney transplantation. Transplantation. 2004 Mar 27; 77(6):838-43.
    View PubMed
  73. Kudva YC, Sawka AM, Young WF. Clinical review 164 - The laboratory diagnosis of adrenal pheochromocytoma: The Mayo Clinic experience. J Clin Endocrinol Metab. 2003 Oct 1; 88(10):4533-9.
    View PubMed
  74. Rajagopalan G, Kudva YC, Chen LP, Wen L, David CS. Autoimmune diabetes in HLA-DR3/DQ8 transgenic mice expressing the co-stimulatory molecule B7-1 in the beta cells of islets of Langerhans. Int Immunol. 2003 Sep; 15(9):1035-44.
    View PubMed
  75. Kudva YC. Antimicrobial treatment did not reduce complications of urinary tract infection in diabetes and asymptomatic bacteriuria. ACP J Club. 2003 May-Jun; 138(3):69.
    View PubMed
  76. Zangeneh F, Kudva YC, Basu A. Insulin sensitizers. Mayo Clin Proc. 2003 Apr; 78(4):471-9.
    View PubMed
  77. Kudva YC, Reynolds CA, O'Brien T, Crotty TB. Mastopathy and diabetes. Current Diabetes Reports. 2003 Feb; 3(1):56-9.
    View PubMed
  78. Rajagopalan G, Kudva YC, Flavell RA, David CS. Accelerated diabetes in rat insulin promoter-tumor necrosis factor-alpha transgenic nonobese diabetic mice lacking major histocompatibility class II molecules. Diabetes. 2003 Feb; 52(2):342-7.
    View PubMed
  79. Kudva YC, Rajagopalan G, Raju R, Abraham RS, Smart M, Hanson J, David CS. Modulation of insulitis and type 1 diabetes by transgenic HLA-DR3 and DQ8 in NOD mice lacking endogenous MHC class II. Hum Immunol. 2002 Nov; 63(11):987-99.
    View PubMed
  80. Kudva YC. A split regimen for regular insulin at dinner and NPH insulin at bedtime reduced nocturnal hypoglycemia in type 1 diabetes. ACP J Club. 2002 Nov-Dec; 137(3):89.
    View PubMed
  81. Kudva YC. Review: intensive insulin pump therapy slightly improves glycemic control in type 1 diabetes. ACP J Club. 2002 Sep-Oct; 137(2):56.
    View PubMed
  82. Montori VM, Basu A, Erwin PJ, Velosa JA, Gabriel SE, Kudva YC. Posttransplantation diabetes - A systematic review of the literature. Diabetes Care. 2002 Mar; 25(3):583-92.
    View PubMed
  83. Kudva YC, Reynolds C, O'Brien T, Powell C, Oberg AL, Crotty TB. "Diabetic mastopathy," or sclerosing lymphocytic lobulitis, is strongly associated with type 1 diabetes. Diabetes Care. 2002 Jan; 25(1):121-6.
    View PubMed
  84. Erickson D, Kudva YC, Ebersold MJ, Thompson GB, Grant CS, van Heerden JA, Young WF Jr. Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients. J Clin Endocrinol Metab. 2001 Nov; 86(11):5210-6.
    View PubMed
  85. Kudva YC, Deng YJ, Govindarajan R, Abraham RS, Marietta EV, Notkins AL, David CS. HLA-DQ8 transgenic and NOD mice recognize different epitopes within the cytoplasmic region of the tyrosine phosphatase-like molecule, IA-2. Hum Immunol. 2001 Oct; 62(10):1099-105.
    View PubMed
  86. Kudva YC, Deng Y, Govindrajan R, Abraham RS, Marietta E, Notkins AL, David CS. The Cytoplasmic Region of IA-2 are Immunogenic in NOD and HLA DQ8 Transgenic Mice. Human Immunol. 2001; 62(10):1099-105.
  87. Abraham RS, Kudva YC, Wilson SB, Strominger JL, David CS. Co-expression of HLA DR3 and DQ8 results in the development of spontaneous insulitis and loss of tolerance to GAD65 in transgenic mice. Diabetes. 2000 Apr; 49(4):548-54.
    View PubMed
  88. Stegall MD, Larson TS, Kudva YC, Grande JP, Nyberg SL, Prieto M, Velosa JA, Rizza RA. Pancreas transplantation for the prevention of diabetic nephropathy. Mayo Clin Proc. 2000 Jan; 75(1):49-56.
    View PubMed
  89. Kudva YC, O'Brien T, Crotty TB. Sclerosing lymphocytic lobulitis or "diabetic mastopathy" is specific for type 1 diabetes mellitus. Diabetes Care. 2000.
  90. Kudva YC, Young WF, Thompson GB, Grant CS, van Heerden JA. Adrenal incidentaloma: an important component of the clinical presentation spectrum of benign sporadic adrenal pheochromocytoma. Endocrinologist. 1999 Mar-Apr; 9(2):77-80.
  91. Kudva YC, Mueske C, Butler PC, Eberhardt NL. A novel assay in vitro of human islet amyloid polypeptide amyloidogenesis and effects of insulin secretory vesicle peptides on amyloid formation. Biochem J. 1998 May 1; 331 ( Pt 3):809-13.
    View PubMed
  92. Kudva YC, Gharib H. Thyroid nodules: approaches to diagnosis and management. Endocr Updates. 1998; 2:139-154.
  93. Kudva YC, Mueske CS, Butler PC, Eberhardt NL. Effect of Insulin Secretory Vesicle Constituents on Human Islet Amyloid Polypeptide (IAPP) Amyloidogenesis in an In vitro Fluorescence Assay. Biochem J 331 809-13,. 1998.
  94. Kudva YC, Young WF Jr. Lightheaded spells and hypertension. Lancet. 1997 Oct 18; 350(9085):1140.
    View PubMed
  95. Kudva YC, Hiddinga HJ, Butler PC, Mueske CS, Eberhardt NL. Small heat shock proteins inhibit in vitro A beta(1-42) amyloidogenesis. FEBS Lett. 1997 Oct 13; 416(1):117-21.
    View PubMed
  96. Kudva YC, Peterson LS, Holley KE, Wright AJ, Hunder GG. SLE nephropathy in a patient with HIV infection: case report and review of the literature. J Rheumatol. 1996 Oct; 23(10):1811-5.
    View PubMed
  97. Kudva YC, Mason TG. 22-year-old man with abdominal pain and rash. Mayo Clin Proc. 1996 May; 71(5):489-92.
    View PubMed
  98. Chintapatla S, Kudva YC, Nayar RC, Raghuveer TS, Prasad D. Septal deviation in neonates. Indian Pediatr. 1989 Jul; 26(7):678-82.
    View PubMed


Appointments | Contact Us | Give to Mayo Clinic | Search

LEGAL RESTRICTIONS AND TERMS OF USE APPLICABLE TO THIS SITE

Use of this site signifies your agreement to the terms of use.
© 2013 Mayo Foundation for Medical Education and Research. All rights reserved.